MedTrace Logo

Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis

NCT00304889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2015-06-03

No results posted yet for this study

Summary

The purpose of this study is to compare the outcome of treatment with nitazoxanide vs. vancomycin for diarrheal disease due to Clostridium difficile in patients who have failed previous treatment with metronidazole.

Conditions

  • Clostridium Enterocolitis
  • Pseudomembranous Colitis
  • Antibiotic-Associated Colitis

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER

  • Michael E. DeBakey VA Medical Center

    lead FED

Principal Investigators

  • Daniel M Musher, M.D. · Houston VA Medical Center, Baylor College of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00304889 on ClinicalTrials.gov